Fees payable for medicinal products and companies

Updated 01 June 2021

The Danish Medicines Agency is a public authority financed primarily by fees and charges from the companies, the reason being that the Danish parliament has decided that companies must pay for the reviews that the Danish Medicines Agency carries out for them. The fees and charges cover the costs of review, for example in relation to applications for authorisation of medicines, laboratory controls, inspections and monitoring of adverse reactions (side effects).

The fees are adjusted annually with changes in the price and wage indices. The Danish Medicines Agency sends out invoices payable within one month.


See the fees that were applicable from 1 January 2020 to 31 December 2020


See the fees that are applicable from 1 January 2020 to 31 December 2021

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.